Who owns APELLIS PHARMACEUTICALS INC?
- CUSIP Number: 03753uab2
Tip: Access positions for across all investors
Analyze quarterly positions in Apellis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Apellis Pharmaceuticals stock
Who bought or sold APELLIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DeepCurrents Investment Group | 45M | $47M | 1% | Mar 2026 |
|
| Linden Advisors | 28M | $29M | 0% | Dec 2025 |
|
| Tenor Capital Management | 12M | $13M | 0% | Mar 2026 |
|
| D. E. Shaw & Co | 5.0M | $5.3M | 0% | Mar 2026 |
|
| Wolverine Asset Management | 3.1M | $3.3M | 0% | Mar 2026 |
|
| Wellington Management Company | 1.1M | $1.2M | 0% | Dec 2025 |
|
| Cantor Fitzgerald, L. P. | 1.1M | $1.2M | 100% | Mar 2026 |
|
| Citigroup | 6.0k | $6.3k | 100% | Mar 2026 |
|
Who sold out of Apellis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Kornitzer Capital Management | Dec 2025 | 300k | $308k |